Isn't Martin Shkreli notorious for hiking prices on drugs, not for pioneering new payment models for drugs? My post was about how if a company had a drug which

Isn't Martin Shkreli notorious for hiking prices on drugs, not for pioneering new payment models for drugs? My post was about how if a company had a drug which it had development cost $X for, it could recoup X + p from the consumer even if the drug is a one time dose rather than an ongoing treatment. How much p profit they make is a separate question and anyways is sort of orthogonal to the question of whether they pay per month or once.